IP Library Granted Patent US 10,712,340
Granted Patent B2
US 10,712,340 · App. 13/744,543 · Granted Jul 14, 2020

Assay device having controllable sample size

Inventors: Edward R. Scalice (Penfield, NY); Philip C. Hosimer (Rochester, NY); Zhong Ding (Pittsford, NY); James D. Kanaley (Honeoye Falls, NY); David A. Tomasso (Rochester, NY); Daniel P. Salotto (Rochester, NY); Timothy C. Warren (Rochester, NY)
Assignee: ORTHO-CLINICAL DIAGNOSTICS, INC.
G01N33/5302G01N33/53G01N33/54386G01N33/558
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,712,340
App. No.
13/744,543
Granted
Jul 14, 2020
Kind
B2
Abstract

Disclosed is an assay device which comprises a liquid sample addition zone, a reagent zone, a detection zone, and a wicking zone, all defining a fluid flow path. The device further comprises a reagent addition zone along and in fluid communication with the fluid flow path downstream of the sample addition zone and upstream of the detection zone. An interrupting wash is added at this reagent addition zone in accordance with the method of the subject invention to control sample volume. The interrupting wash fluid is added at a predetermined fill volume on the chip device and also serves to wash the detection channel and fill the remaining chip volume.

Claims (16)

1. A method of controlling sample size in an assay device, said assay device comprising a substrate having a planar top surface, said method comprising:

providing a liquid sample addition zone on the planar top surface of the substrate;

providing a reagent zone on the planar top surface of the substrate, the reagent zone being provided downstream and in fluid communication with the sample addition zone and containing a reagent, said reagent including a material that produces a detectable signal in the presence of a sample;

providing a detection zone on the planar top surface of the substrate in fluid communication with the reagent zone;

providing a wicking zone on the planar top surface of the substrate in fluid communication with the detection zone having a capacity to receive liquid sample flowing from the detection zone, wherein the sample addition zone, the reagent zone, the detection zone and the wicking zone define a fluid flow path formed on the planar top surface of the substrate, the fluid flow path being configured to enable capillary flow from the sample addition zone to the wicking zone by means of projections formed on the planar top surface of the substrate, the projections having height and width dimensions, as well as spacing between adjacent projections that spontaneously create lateral capillary flow along the fluid flow path;

further providing a fluid addition zone on the planar top surface of the substrate, the fluid addition zone being along and in fluid communication with the fluid flow path downstream of the sample addition zone and the reagent zone and upstream of the detection zone;

adding sample to the sample addition zone, wherein the sample moves through the fluid flow path due to the capillary action of the projections;

allowing the sample to mix with the reagent in the reagent zone; and

controlling sample size within the fluid flow path by adding an interrupting fluid to the fluid addition zone after the sample has passed through the reagent zone, mixed with the reagent, and moved a predetermined percentage into the wicking zone, the added fluid creating a dome-shaped droplet that interrupts the capillary flow of sample along the fluid flow path.

2. The method as claimed in claim 1 including the step of adding a wash reagent as the fluid added to the fluid addition zone.

3. The method as claimed in claim 1 wherein the sample is whole blood and further including the step of adding a fluid to the sample addition zone, the fluid including a surfactant.

4. A method as claimed in claim 3 wherein the surfactant is deposited on the sample addition zone before the sample is added to the sample addition zone.

5. A method as claimed in claim 1 further comprising providing a filter on the sample addition zone, wherein sample passes through the filter before entering the fluid flow path.

6. A method as claimed in claim 1 further comprising providing a hydrophilic tape at least partially covering the detection zone.

7. A method as claimed in claim 1 , in which the fluid is added after the sample has filled at least 20% of the wicking zone.

8. A method as claimed in claim 1 , in which the fluid is added after the sample has filled at least 50% of the wicking zone.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: SCALICE, EDWARD R.; HOSIMER, PHILIP C.; DING, ZHONG; KANALEY, JAMES D.; TOMASSO, DAVID A.; SALOTTO, DANIEL P.; WARREN, TIMOTHY C.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 029655/0504 →